Skip to main content
Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
9.17
+0.10 (1.10%)
Mar 9, 2026, 1:32 PM EDT - Market open

Embecta Revenue

Embecta had revenue of $261.20M in the quarter ending December 31, 2025, a decrease of -0.27%. This brings the company's revenue in the last twelve months to $1.08B, down -2.53% year-over-year. In the fiscal year ending September 30, 2025, Embecta had annual revenue of $1.08B, down -3.80%.

Revenue (ttm)
$1.08B
Revenue Growth
-2.53%
P/S Ratio
0.50
Revenue / Employee
$583,622
Employees
1,850
Market Cap
543.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20251.08B-42.70M-3.80%
Sep 30, 20241.12B2.30M0.21%
Sep 30, 20231.12B-8.70M-0.77%
Sep 30, 20221.13B-35.80M-3.07%
Sep 30, 20211.17B79.80M7.35%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Azenta 595.03M
AngioDynamics 307.31M
STAAR Surgical Company 239.44M
OraSure Technologies 115.02M
BioLife Solutions 96.21M
Kestra Medical Technologies 74.26M
KORU Medical Systems 39.07M
Utah Medical Products 38.52M
Revenue Rankings

EMBC News

More News